close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

460.42 +0.14 (+0.03%)
Delayed Quote Updated: 4:00 PM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Amgen

< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
News headline image
After the Midterm Rally, the Dow Is on Track to Beat the Nasdaq for the First Time Since 2022. Here's What History Says Could Come Next. ↗
The Dow tends to outperform the Nasdaq during growth stock-driven sell-offs. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
1 unpopular stock that should get more attention and 2 we question
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
Topics Regulatory Compliance
News headline image
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027? ↗
Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than many expect. 
Via The Motley Fool
Topics Intellectual Property
Amgen (NASDAQ:AMGN) Q3 2026: EPS Beat, Revenue In Line as Shares Dip After-Hours ↗
Via Chartmill
Dow Jones Top Gainers in Today's Session: 3M Leads ↗
Via Chartmill
Topics Stocks
News headline image
Amgen (AMGN) Q3 2026 Earnings Call Transcript ↗
Six growth drivers now account for 70% of product sales as guidance was raised. 
Via The Motley Fool
Topics Earnings
S&P 500 Premarket Movers for Nov. 4 ↗
Via Chartmill
Topics Stocks
News headline image
AMGN Q3 2026 deep dive: robust product sales and pipeline advances drive guidance increase
Biotech company Amgen (NASDAQ:AMGN) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 8.5% year on year to $10.37 billion. ... 
Via StockStory
News headline image
What Amgen (AMGN) Said on Its Q3 Earnings Call ↗
Amgen (NASDAQ:AMGN) reported third-quarter revenue growth of 8% year over year to $10.4 billion, supported by broad-based demand across its portfolio and continued clinical progress in several... 
Via MarketBeat
Topics ETFs Earnings
Dow Jones Top Gainers on Oct. 20, 2026: MMM, UNH, MRK Lead Session ↗
Via Chartmill
Topics Stocks
News headline image
Amgen (NASDAQ:AMGN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
Biotech company Amgen (NASDAQ:AMGN) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 8.5% year on year to $10.37 billion. The company’s fu... 
Via StockStory
News headline image
Amgen Just Gave Its Shareholders Great News ↗
The red-hot healthcare stock may soon have another catalyst that drives its value even higher. 
Via The Motley Fool
News headline image
Amgen (AMGN) reports Q3: everything you need to know ahead of earnings
Biotech company Amgen (NASDAQ:AMGN) will be reporting results this Tuesday after market hours. Here’s what you need to know. Amgen beat analysts’ revenue exp... 
Via StockStory
News headline image
Looking For Growth, Income, and Stability? This Stock Could Offer All 3 ↗
Amgen can appeal to various kinds of investors. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue ↗
Amgen's quarterly revenue swings between $8.1B and $10.1B, while Vertex climbs steadily from $2.8B to $3.3B—a tale of scale versus trajectory. 
Via The Motley Fool
Topics Intellectual Property Lawsuit
News headline image
Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026? ↗
Amgen's 9.9% revenue growth outpaces Novo Nordisk, but a 33.1% net margin and lower valuation multiples tell a different profitability story. 
Via The Motley Fool
News headline image
Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? ↗
Both of these biotech stocks could be appealing to income investors. 
Via The Motley Fool
News headline image
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study ↗
Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance... 
Via MarketBeat
Topics ETFs
News headline image
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? ↗
Amgen trades at a lower valuation multiple, but Johnson & Johnson's fortress balance sheet and stronger free cash flow tell a different story about financial resilience. 
Via The Motley Fool
News headline image
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026? ↗
Amgen trades at half the valuation multiple of Eli Lilly while generating stronger free cash flow, but explosive growth in obesity drugs tells a different story. 
Via The Motley Fool
Dow Jones Top Movers Today: PG and JNJ Lead Gainers, CAT and AMZN Lead Losers ↗
Via Chartmill
Topics Stocks
Dow Jones Top Movers: Gainers and Losers on October 22, 2026 ↗
Via Chartmill
Topics Stocks
News headline image
Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? ↗
Amgen boasts stronger revenue growth, while Bristol Myers Squibb generates nearly 60% more free cash flow at half the valuation. 
Via The Motley Fool
News headline image
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) ↗
These drugmakers are facing some near-term challenges, but is that enough to stop their recent momentum? 
Via The Motley Fool
Discover which dow jones stocks are making waves on Thursday. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
Boeing's Secret Weapon Isn't on the Factory Floor -- It's in the Boardroom ↗
The company's board of directors can play a vital role in positioning the company to develop the next generation of aircraft. 
Via The Motley Fool
Discover which dow jones stocks are making waves on Wednesday. ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
69 70 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.